Related references
Note: Only part of the references are listed.Non-Amyloid Approaches to Disease Modification for Alzheimer's Disease: An EU/US CTAD Task Force Report
S. Gauthier et al.
JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE (2020)
The Future of Anti-Amyloid Trials
P. S. Aisen et al.
JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE (2020)
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype
Lisa Vermunt et al.
ALZHEIMERS & DEMENTIA (2019)
Multidomain intervention and/or omega-3 in nondemented elderly subjects according to amyloid status
Julien Delrieu et al.
ALZHEIMERS & DEMENTIA (2019)
Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression
Xinyi Wang et al.
CELL RESEARCH (2019)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Homocysteine and Dementia: An International Consensus Statement
A. David Smith et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease
Andrew J. Aschenbrenner et al.
NEUROLOGY (2018)
Brain morphology links systemic inflammation to cognitive function in midlife adults
Anna L. Marsland et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
Long-term effects of Aβ42 immunisation in Alzheimer's disease:: follow-up of a randomised, placebo-controlled phase I trial
Clive Holmes et al.
LANCET (2008)
Amyloids, prions and the inherent infectious nature of misfolded protein aggregates
C Soto et al.
TRENDS IN BIOCHEMICAL SCIENCES (2006)
Share Paper
